1. Fernandez MD, Burn JI, Sauven PD, Parmar G, White JO, Myatt L (1984) Activated estrogen receptors in breast cancer and response to endocrine therapy. Eur J Cancer Clin Oncol 20:41–46
2. McGuire AH, Dehdashti F, Siegel BA, Lyss AP, Brodack JW, Mathias CJ, Mintun MA, Katzenellenbogen JA, Welch MJ (1991) Positron tomographic assessment of 16-alpha-[18F] fluoro-17-beta-estradiol uptake in metastatic breast carcinoma. J Nucl Med 32:1526–1531
3. McManaway ME, Jagoda EM, Kasid A, Echelman WC, Francis BE, Larson SM, Gibson RE, Reba RC, Lippman ME (1987) [125I]17-beta-iodovinyl-11-beta-methoxyes-tradiol interaction in vivo with estrogen receptors in hormone-independent MCF-7 human breast cancer transfected with the v-rasH oncogene. Cancer Res 47:2945–2949
4. Jagoda EM, Gibson RE, Goodgold H, Ferreira N, Francis BE, Reba RC, Rzeszotarski WJ, Eckelman WC (1984) [125I]17 alpha-iodovinyl-11-beta-methoxyestra-diol: in vivo and in vitro properties of a high affinity estrogen-receptor radiopharmaceutical. J Nucl Med 25:472–477
5. Hamm JT, Allegra JC (1991) Hormonal therapy for cancer. In: Witts RE (ed.) Manual of oncologic therapeutics. Lippincott, New York, pp 122–126